Skip to main content
Veterinary Medicines

Fasinex 240 mg/ml oral suspension for cattle

Authorised
  • Triclabendazole

Product identification

Medicine name:
Fasinex 240 mg/ml oral suspension for cattle
Active substance:
  • Triclabendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    240.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        56
        day
      • Milk
        37
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC01
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • High density polyethylene bottles of 12.0 litres.
  • High density polyethylene bottles of 5.0 litres.
  • High density polyethylene bottles of 2.2 litres.
  • High density polyethylene bottles of 0.8 litres.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22020/003/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."